Moderna Maintains Vaccine Sales View on Lower COVAX Orders
KONTAN.CO.ID - Moderna Inc on Wednesday retained its full-year sales outlook for Covid-19 shot at US$ 21 billion due to a decrease in orders from low- and middle-income countries through the COVAX international vaccine-sharing program.
The company kept its forecast unchanged despite announcing a new US$ 1,74 billion deal with the US government for 66 million Covid-19 booster doses last week.
